UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.209-219

2018

Volltextzugriff (PDF)

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

Thrombosis journal, 2016-12, Vol.14 (1), p.49-49, Article 49

2016

Volltextzugriff (PDF)

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’

Thrombosis research, 2022-06, Vol.214, p.63-64

2022

Volltextzugriff (PDF)

Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma

Thrombosis research, 2024-12, Vol.244, p.109194, Article 109194

2024

Volltextzugriff (PDF)

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Thrombosis and haemostasis, 2013, Vol.110 (3), p.543-549

2013

Volltextzugriff (PDF)

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Thrombosis journal, 2020-09, Vol.18 (1), p.17-16, Article 17

2020

Volltextzugriff (PDF)

Clotting test results correlate better with DOAC concentrations when expressed as a “Correction Ratio”; results before/after extraction with the DOAC Stop reagent

Thrombosis research, 2019-07, Vol.179, p.69-72

2019

Volltextzugriff (PDF)

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study

Thrombosis research, 2023-01, Vol.221, p.69-72

2023

Volltextzugriff (PDF)

Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2548-2552

2016

Volltextzugriff (PDF)

Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants

Thrombosis research, 2020-01, Vol.185, p.72-77

2020

Volltextzugriff (PDF)

Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-12, Vol.16 (12), p.2526-2529

2018

Volltextzugriff (PDF)

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Thrombosis research, 2014-06, Vol.133 (6), p.1068-1073

2014

Volltextzugriff (PDF)

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.693-696

2013

Volltextzugriff (PDF)

Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

Journal of virological methods, 2021-03, Vol.289, p.114060-114060, Article 114060

2021

Volltextzugriff (PDF)

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1679-1681

2011

Volltextzugriff (PDF)

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Thrombosis research, 2014-06, Vol.133 (6), p.1074-1078

2014

Volltextzugriff (PDF)

Andexanet alfa for the reversal of factor Xa inhibitors

Expert opinion on biological therapy, 2019-05, Vol.19 (5), p.387-397

2019

Volltextzugriff (PDF)

D-dimer testing: A narrative review

Advances in clinical chemistry, 2023, Vol.114, p.151-223

2023

Volltextzugriff (PDF)

Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme

International journal of laboratory hematology, 2017-08, Vol.39 (4), p.402-408

2017

Volltextzugriff (PDF)

Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

International journal of laboratory hematology, 2018-12, Vol.40 (6), p.e105-e108

2018

Volltextzugriff (PDF)

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1166-1168

2015

Volltextzugriff (PDF)

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Thrombosis research, 2013-09, Vol.132 (3), p.352-359

2013

Volltextzugriff (PDF)

A reminder of the place of morphology and the H‐score in the diagnosis of hemophagocytic lymphohistiocytosis (HLH)

Clinical case reports, 2018-03, Vol.6 (3), p.527-528

2018

Volltextzugriff (PDF)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Thrombosis and haemostasis, 2013-08, Vol.110 (2), p.283-294

2013

Volltextzugriff (PDF)

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Thrombosis and haemostasis, 2013-10, Vol.110 (4), p.723-731

2013

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(93)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’

Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Clotting test results correlate better with DOAC concentrations when expressed as a “Correction Ratio”; results before/after extraction with the DOAC Stop reagent

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study

Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH

Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants

Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Andexanet alfa for the reversal of factor Xa inhibitors

D-dimer testing: A narrative review

Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme

Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

A reminder of the place of morphology and the H‐score in the diagnosis of hemophagocytic lymphohistiocytosis (HLH)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Suchergebnisse filtern